Department of Chongqing Brewery Great potential re

did not significantly push up the share price.
Chongqing Brewery no longer simply a business filled with beer foam,
However, this return is the result of them waiting for nearly two years. In 2009, the Shanghai Composite Index rose 79.98%, more than half of the stock's share price rose more than double the same period, Chongqing Brewery shares rose only 27%. Shenzhen, Chongqing Beer who is familiar with the seller, analysts said institutional investors about the company was
in the February 16, 2009 afternoon, the Deputy General Manager and Chief Financial Officer Tang Wei received the Dacheng Fund Chief Investment Officer Liu, Yang Jianhua, director of equity investments and the pharmaceutical industry researchers,
data show that the first quarter of 2009, Chongqing Brewery's share price from the lowest 13 yuan / share rose to the highest 23.79 yuan, and in March 30 to close at 21.12 yuan. The average price of 18 yuan / share basis, Dacheng Fund in Chongqing beer more than 4 times the return on this investment.
Dacheng Fund to a year ahead of mining and layout of this big bull stock? is how they found the Chongqing Beer and get 4 times the value of the return?
Chongqing Brewery, in the recent month. From 2010 September 1 to November 16,a&f t-shirt, its share price climbed all the way from the 37.60 yuan to 79.98 yuan, an increase of 109.42%,prada wallet, significantly beyond the medical index of 14.37% over the same period a year earlier.
patients who were followed up for trial. August 2008 found that the third follow-up 10 patients into three positive in 3 of 5 patients in the DNA levels dropped significantly. reasons.
latent two years, the return of 4 times
up in this wave,cufflinks paul smith, Dacheng Fund to become the biggest winner. According to the Chongqing Beer 2010 Report of the first three quarters, the Dacheng Dacheng Fund's innovation,,, Great selection,, 2020, etc. 6 Dacheng Fund, which together hold up to 4316.3 million shares of Chongqing Brewery.

In fact, the Chongqing Beer Shigekura Dacheng Fund gains far more than 210%, from February 2009 onwards, the layout Dacheng Fund to Shigekura Chongqing Beer, return on investment of up to 4 times.
but the progress of the project was not successful, most investors believe that the Chongqing Beer efficacy of hepatitis B vaccine is not.
Dacheng Fund
The soaring prices
Chongqing Beer in the market is not optimistic, the public information display, Dacheng Fund since early 2009, after buying beer has been held in Chongqing. Chongqing beer to attract them is the story behind - a project on the treatment of hepatitis B vaccine.
massive presence in the first quarter of 2009: the end of 2008, Tai Shing's only a 0.14% held by the Fund outstanding shares of Chongqing Brewery, and a quarter by 2009, Dacheng Innovation Growth, Great wealth management, etc. 7 2020 only the funds coming out their mouths before the ten tradable shares, the total stake to 8.02%.
1998, the Chongqing Brewery began to hepatitis B vaccine, to develop a country with completely independent intellectual property rights of a class of drugs - therapeutic use (synthetic peptide) hepatitis B vaccine.
After years of silence, in June 2005, Chongqing Beer announcement that Supervisor Board approval to enter the most critical clinical trial phase II. March 31, 2006, held in Beijing,tory burch, Chongqing Brewery Ⅱ will start clinical studies.
research in general is different from Dacheng Fund in Chongqing to be a whole week, they found the person responsible for the vaccine project Professor Wu Yuzhang, Clinical Hospital, the investment bank to do the project sponsor, Chongqing Brewery's former and current chairman of the board full understanding of the situation and other vaccines.
from year-to-2 December, the Shanghai index down more than 200 points, or nearly 13%. But the largest holding Dacheng Fund (600132.SH) over the same period rose 210% was obtained substantial excess returns.
hepatitis B vaccine is expected